IL143376A0 - Ethanolate of azithromycin, process for the manufacture, and pharmaceutical compositions thereof - Google Patents

Ethanolate of azithromycin, process for the manufacture, and pharmaceutical compositions thereof

Info

Publication number
IL143376A0
IL143376A0 IL14337699A IL14337699A IL143376A0 IL 143376 A0 IL143376 A0 IL 143376A0 IL 14337699 A IL14337699 A IL 14337699A IL 14337699 A IL14337699 A IL 14337699A IL 143376 A0 IL143376 A0 IL 143376A0
Authority
IL
Israel
Prior art keywords
ethanolate
azithromycin
manufacture
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
IL14337699A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22332273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL143376(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL143376A0 publication Critical patent/IL143376A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL14337699A 1998-11-30 1999-11-30 Ethanolate of azithromycin, process for the manufacture, and pharmaceutical compositions thereof IL143376A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11029898P 1998-11-30 1998-11-30
PCT/US1999/028368 WO2000032203A1 (en) 1998-11-30 1999-11-30 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
IL143376A0 true IL143376A0 (en) 2002-04-21

Family

ID=22332273

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14337699A IL143376A0 (en) 1998-11-30 1999-11-30 Ethanolate of azithromycin, process for the manufacture, and pharmaceutical compositions thereof

Country Status (26)

Country Link
US (1) US6365574B2 (it)
EP (2) EP1484062A1 (it)
JP (1) JP2002531409A (it)
KR (1) KR100603226B1 (it)
CN (2) CN100339384C (it)
AP (1) AP1709A (it)
AT (1) ATE279200T1 (it)
AU (1) AU768219B2 (it)
BG (1) BG105547A (it)
CA (1) CA2352562A1 (it)
CZ (1) CZ20011886A3 (it)
DE (1) DE69921192T2 (it)
DK (1) DK1152765T3 (it)
ES (1) ES2229804T3 (it)
HK (1) HK1043725B (it)
HU (1) HUP0104241A3 (it)
IL (1) IL143376A0 (it)
LV (1) LV12735B (it)
NZ (1) NZ512496A (it)
PL (1) PL197894B1 (it)
PT (1) PT1152765E (it)
RO (1) RO121408B1 (it)
RU (1) RU2240124C2 (it)
SI (1) SI20639A (it)
WO (1) WO2000032203A1 (it)
ZA (1) ZA200104312B (it)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
CZ20011886A3 (cs) * 1998-11-30 2001-10-17 Teva Pharmaceutical Industries Ltd. Etanolát azitromycinu, postup přípravy a jeho farmaceutické preparáty
JP2004519430A (ja) * 2000-11-27 2004-07-02 バイオケミ・エセ・ア マクロライドの溶媒和物
UA76967C2 (uk) * 2000-11-27 2006-10-16 Сандоз Аг Азитроміцин у формі моногідрату, фармацевтична композиція та спосіб його одержання
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
EE200300575A (et) 2001-05-22 2004-04-15 Pfizer Products Inc. Asitromütsiini kristalsed vormid
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
SI1390377T1 (sl) * 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
EP1541134A3 (en) * 2001-10-18 2007-06-06 Teva Pharmaceutical Industries Limited Stabilized azithromycin compositions
HUP0402291A2 (hu) * 2001-10-18 2005-03-29 Teva Pharmaceutical Industries Ltd. Stabilizált azithromycin összetételek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
JP2005513099A (ja) * 2001-12-21 2005-05-12 ファイザー・プロダクツ・インク アジスロマイシンの直接的に圧縮可能な配合品
RU2283651C2 (ru) * 2001-12-21 2006-09-20 Пфайзер Продактс Инк. Способы мокрой грануляции азитромицина
EP1478347A1 (en) * 2002-02-01 2004-11-24 Pfizer Products Inc. Dry granulated formulations of azithromycin
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
ATE399536T1 (de) * 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
CA2547239A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
BRPI0417348A (pt) * 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
WO2006067577A2 (en) * 2004-12-21 2006-06-29 Pfizer Products Inc. Stable non-dihydrate azithromycin oral suspensions
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
US9433516B2 (en) * 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
JP2012520268A (ja) 2009-03-13 2012-09-06 ダ・ボルテラ グラム陰性細菌の除去のための組成物及び方法
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN103983730B (zh) * 2014-06-11 2015-09-30 北京市药品检验所 阿奇霉素或其制剂中的杂质检查方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
UA27040C2 (uk) * 1987-07-09 2000-02-28 Пфайзер Інк. Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
CN1093370A (zh) 1993-12-10 1994-10-12 北京市集才药物研究所 一种新的阿齐红霉素结晶及其制备方法
CN1161971A (zh) * 1997-01-03 1997-10-15 石家庄制药集团有限公司 一种阿齐霉素结晶及其制备方法
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
CZ20011886A3 (cs) * 1998-11-30 2001-10-17 Teva Pharmaceutical Industries Ltd. Etanolát azitromycinu, postup přípravy a jeho farmaceutické preparáty
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
EE200300575A (et) * 2001-05-22 2004-04-15 Pfizer Products Inc. Asitromütsiini kristalsed vormid

Also Published As

Publication number Publication date
EP1484062A1 (en) 2004-12-08
AP1709A (en) 2007-02-27
PT1152765E (pt) 2004-12-31
RU2240124C2 (ru) 2004-11-20
CA2352562A1 (en) 2000-06-08
JP2002531409A (ja) 2002-09-24
ES2229804T3 (es) 2005-04-16
SI20639A (sl) 2002-02-28
LV12735A (en) 2001-10-20
US6365574B2 (en) 2002-04-02
EP1152765A4 (en) 2002-07-17
LV12735B (en) 2002-03-20
RO121408B1 (ro) 2007-05-30
DK1152765T3 (da) 2005-01-31
HUP0104241A2 (hu) 2002-03-28
NZ512496A (en) 2003-02-28
AP2001002183A0 (en) 2001-06-30
BG105547A (en) 2001-12-31
US20020007049A1 (en) 2002-01-17
PL347971A1 (en) 2002-05-06
CN100339384C (zh) 2007-09-26
CN1737008A (zh) 2006-02-22
AU768219B2 (en) 2003-12-04
AU3106500A (en) 2000-06-19
KR100603226B1 (ko) 2006-08-28
HUP0104241A3 (en) 2003-12-29
ATE279200T1 (de) 2004-10-15
CN1334735A (zh) 2002-02-06
CN1273142C (zh) 2006-09-06
EP1152765B1 (en) 2004-10-13
CZ20011886A3 (cs) 2001-10-17
HK1043725B (zh) 2005-05-06
KR20010099806A (ko) 2001-11-09
ZA200104312B (en) 2001-11-28
PL197894B1 (pl) 2008-05-30
DE69921192T2 (de) 2006-02-16
EP1152765A1 (en) 2001-11-14
HK1043725A1 (en) 2002-09-27
WO2000032203A1 (en) 2000-06-08
DE69921192D1 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
IL143376A0 (en) Ethanolate of azithromycin, process for the manufacture, and pharmaceutical compositions thereof
HUP0003309A3 (en) Imidazolyl-cyclic acetals, process for producing them and pharmaceutical compositions containing the same
AU4048299A (en) Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
HUP9900120A3 (en) Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HUP9900163A2 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
HUP0102084A3 (en) Quinoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0103224A3 (en) Quinoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0105480A3 (en) Benzofuran derivatives, process for preparation of the same and uses thereof
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
PL349448A1 (en) Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HK1039122A1 (zh) 取代的6-苄基-4-氧代嘧啶,其製備方法以及含該化合物的藥物組合物
IL129906A0 (en) Process for the preparation of beta-isophorone
IL145520A0 (en) Flame-retarding composition and process for the preparation thereof
HUP0102042A3 (en) New pentasaccharides, their methods of production and pharmaceutical compositions comprising same
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
HUP9801548A3 (en) Blowing agent powder and process for producing the same
HUP0101256A3 (en) Pharmaceutical composition having antitumor activity and process for the preparation thereof
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
AU4659199A (en) Process for the preparation of urea
HUP0104202A3 (en) Thiazole-derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0104544A2 (en) New pharmaceutical composition and the process for its preparation
HUP9904564A3 (en) Substituted aminomethyl-cycloheptenes, process for producing them, their use, and pharmaceutical compositions containing them
HUP9902745A3 (en) Process for the preparation of benzylcarbazate